These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 14387889)

  • 21. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel MRI marker for prostate brachytherapy.
    Frank SJ; Stafford RJ; Bankson JA; Li C; Swanson DA; Kudchadker RJ; Martirosyan KS
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):5-8. PubMed ID: 18406882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bank filtration: a suitable process for the removal of iodinated X-ray contrast media?
    Schittko S; Putschew A; Jekel M
    Water Sci Technol; 2004; 50(5):261-8. PubMed ID: 15497856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAMAM dendrimer based macromolecules as improved contrast agents.
    Venditto VJ; Regino CA; Brechbiel MW
    Mol Pharm; 2005; 2(4):302-11. PubMed ID: 16053333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
    Guevara M; Fernández-Esparrach G; Alessandria C; Torre A; Terra C; Montañà X; Piera C; Alvarez ML; Jiménez W; Ginès P; Arroyo V
    Hepatology; 2004 Sep; 40(3):646-51. PubMed ID: 15349903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STIR vs. T1-weighted fat-suppressed gadolinium-enhanced MRI of bone marrow edema of the knee: computer-assisted quantitative comparison and influence of injected contrast media volume and acquisition parameters.
    Mayerhoefer ME; Breitenseher MJ; Kramer J; Aigner N; Norden C; Hofmann S
    J Magn Reson Imaging; 2005 Dec; 22(6):788-93. PubMed ID: 16270290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
    Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
    J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment.
    Aliev G; Obrenovich ME; Seyidova D; Rzayev NM; Aliyev AS; Raina AK; Lamanna JC; Smith MA; Perry G
    J Submicrosc Cytol Pathol; 2003 Jul; 35(3):253-66. PubMed ID: 14690173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast media inhibit exogenous surfactant therapy in rats with acute respiratory distress syndrome.
    Kesecioglu J; Haitsma JJ; Schultz MJ; den Heeten GJ; Lachmann B
    Clin Physiol Funct Imaging; 2006 Mar; 26(2):120-6. PubMed ID: 16494603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Statistical evaluation of the usefulness of the urinary excretion of radioactive iodine labeled iodipamide as a liver function test; contribution to relative effectiveness of various liver function test].
    KUHNE P; KORTGE P; BILLION H
    Klin Wochenschr; 1957 Jun; 35(12):616-22. PubMed ID: 13450281
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research on the distribution of radioactive urographin in the human organism].
    SCHLUNGBAUM W; BILLION H
    Klin Wochenschr; 1956 Jun; 34(23-24):633-5. PubMed ID: 13347027
    [No Abstract]   [Full Text] [Related]  

  • 36. [Distribution of radioactive perabrodil M in the human organism and its use in kidney clearance tests].
    BILLION H; SCHLUNGBAUM W
    Klin Wochenschr; 1955 Dec; 33(45-46):1089-93. PubMed ID: 13287017
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution and secretion of radioactive biliselectan and biligrafin in man].
    BILLION H; FROMMHOLD W; OEFF K; SCHUTZ W
    Arztl Wochensch; 1955 Jun; 10(25):574-7. PubMed ID: 14387889
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative studies with radioactive biliselectan and biligraffin].
    BILLION H
    Dtsch Med J; 1954 Apr; 5(8):214-7. PubMed ID: 13173323
    [No Abstract]   [Full Text] [Related]  

  • 39. [The problem of a liver function test with radioactive biliselectan].
    OEFF K; FROMMHOLD W; PEZOLD FA; SCHUCHTER A
    Klin Wochenschr; 1953 Feb; 31(5-6):123-6. PubMed ID: 13070419
    [No Abstract]   [Full Text] [Related]  

  • 40. [Paper electrophoretic studies on the binding of radioactive biliselectan to serum albumin].
    OEFF K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 222(6):523-8. PubMed ID: 13214112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.